Simon Badin in Jersey City, New Jersey

Home New Jersey Jersey City

Simon Badin has Hematology/oncology as his primary medical specialty. Their primary office is: 1947 John F Kennedy Blvd in Jersey City, New Jersey. There is an additional office location, for a total of two, for Simon Badin that can be viewed further down.

They're a part of the: Michel S. Badin, Md Pa medical group which has around 3 members. You can call their office at 201-433-4848 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2006 (around 18 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Simon Badin Office Phone and Directions

Simon Badin
Michel S. Badin, Md Pa
1947 John F Kennedy Blvd
Jersey City, New Jersey 07305
201-433-4848

Patient Ratings
Please rate your experience with Simon Badin below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 201-433-4848

Enter a starting address:

Healthcare Info for Simon Badin

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2006
The Primary Medical Specialty for Simon Badin is listed as: Hematology/oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 1557521028
NPI #: 1467699405
NPI Created On: 01/13/2009
NPI Last Updated Listed as: 03/10/2012
Primary Taxonomy Code: 207RH0003X
License Number:
25MA09050500
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
Oscar Garden State Insurance Corporation
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Arabic, Arabic,Spanish, English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy, prevention, or diagnosis
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Injection, denosumab, 1 mg
Injection, dexamethasone sodium phosphate, 1 mg
Injection, diphenhydramine hcl, up to 50 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788285307

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $65

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008047

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 793954539

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818731845

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERBITUX

Open Associated Drug #1: 66733-958-23

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: CYRAMZA

Associated Drug #2: 0002-7669-01

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802891001

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ZEJULA

Open Associated Drug #1: 69656-103-90

Payments Total: $12

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783716947

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ONUREG

Open Associated Drug #1: 59572-730-14

Payments Total: $14

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783716945

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hematology

Name of Drug #1: Revlimid

Open Associated Drug #1: 59572-405-28

Payments Total: $14

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783717015

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Hematology

Name of Drug #1: Pomalyst

Open Associated Drug #1: 59572-502-00

Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783597329

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $15

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783597335

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Additional Office Locations

1. Michel S Badin Md Llc
1947 John F Kennedy Blvd
Jersey City, NJ 07305
Group Members: 4

Enter a starting address:

Hematology/oncology Professionals in Jersey City

1.
Mark Druck

2 Journal Sq
Jersey-city, NJ
Medical Associates Of Englewood Pc

2.
Kristine Badin

1947 John F Kennedy Blvd
Jersey-city, NJ
Michel S Badin Md Llc

3.
Michel Badin MD

1947 John F Kennedy Blvd
Jersey-city, NJ
Michel S. Badin, Md Pa

4.
Michel Badin MD

1947 John F Kennedy Blvd
Jersey-city, NJ
Michel S Badin Md Llc

5.
Cornel Mircea MD

324 Palisade Ave
Jersey-city, NJ
Optum Medical Care Of New Jersey Pc

6.
Allan Louie Cruz

355 Grand St
Jersey-city, NJ
Barnabas Health Medical Group Pc

Providers in Michel S. Badin, Md Pa

1.Simon Badin

1947 John F Kennedy Blvd
Jersey City Nj 07305-1436
Michel S. Badin, Md Pa
Hematology/oncology

2.Michel Badin Md

1947 John F Kennedy Blvd
Jersey City Nj 07305-1436
Michel S. Badin, Md Pa
Hematology/oncology

3.Diane Badin

1947 John F Kennedy Blvd
Jersey City Nj 07305-1436
Michel S. Badin, Md Pa
Internal Medicine

View all 3 members of Michel S. Badin, Md Pa medical group